ProMIS Neurosciences Inc. (PMN)
NASDAQ: PMN
· Real-Time Price · USD
0.61
-0.02 (-3.17%)
At close: Aug 15, 2025, 3:59 PM
0.61
0.41%
After-hours: Aug 15, 2025, 07:17 PM EDT
ProMIS Neurosciences Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | 6.28K | n/a | n/a | n/a | -4.17K | n/a | n/a | 3.34K | 4.14K | 4K | n/a | n/a |
Cost of Revenue | n/a | 6.22M | 3.47M | 2.22M | 2.88M | 18.02K | 345.00 | 1.24K | 1.55K | 1.56K | 3.15K | n/a | n/a | 3.6M | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | -11.74K | -344 | -1.24K | -1.55K | -5.73K | -3.15K | -3.41K | 3.34K | 4.14K | 4K | n/a | n/a |
Operating Income | -7.46M | -6M | -4.43M | -2.71M | -3.68M | -5.13M | -2.52M | -2.9M | -4.97M | -8.52M | -6.05M | -4.87M | -3.94M | -5.11M | -2.07M | -1.1M | -461K |
Interest Income | n/a | n/a | n/a | n/a | n/a | -65.15 | n/a | 65.15 | n/a | n/a | n/a | n/a | 6.66K | 4.73K | n/a | n/a | n/a |
Pretax Income | -7.35M | -238K | 9.28M | -2.62M | -3.63M | -3.58M | -2.36M | -2.31M | -4.96M | -9.84M | -5.96M | -2.75M | -2.1M | -2.3M | -1.21M | -226K | -6.02M |
Net Income | -7.35M | -342K | 9.28M | -2.62M | -3.63M | -4.74M | -2.36M | -2.31M | -4.96M | -9.84M | -5.96M | -2.75M | -2.1M | -2.3M | -1.21M | -226K | -6.02M |
Selling & General & Admin | 2M | 1.68M | 1.87M | 1.09M | 1.55M | 1.63M | 1.38M | 1.89M | 1.46M | 2.14M | 1.48M | 1.64M | 1.6M | 2.1M | 668.5K | 351.11K | 307.7K |
Research & Development | 5.46M | 6.22M | 2.56M | 1.63M | 2.12M | 2.95M | 1.55M | 1.01M | 4.74M | 8.64M | 4.57M | 3.23M | 2.38M | 3.03M | 1.02M | 935.14K | 153.63K |
Other Expenses | n/a | -6.42M | n/a | n/a | n/a | -2.95M | 113.29K | 30.88K | 52.91K | -8.64M | 35.85K | 16.29K | n/a | n/a | -1.02M | -935K | n/a |
Operating Expenses | 7.46M | 6M | 2.53M | 1.49M | 3.68M | 2.19M | 1.87M | 2.51M | 4.97M | 8.52M | 6.05M | 4.87M | 3.27M | 2.15M | 1.6M | 435.29K | 461.33K |
Interest Expense | n/a | n/a | n/a | n/a | 76.78K | 76.8K | 75.41K | 49.18K | n/a | n/a | n/a | 134.29K | 147.77K | 146.31K | 140.91K | 133.69K | 1.72K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.46M | 6M | 4.43M | 2.71M | 3.68M | 5.13M | 2.52M | 2.9M | 4.97M | 8.52M | 6.05M | 4.87M | 3.94M | 5.12M | 2.07M | 1.11M | 461.33K |
Income Tax Expense | n/a | n/a | n/a | n/a | -7.17K | n/a | n/a | n/a | -11.24K | -2.25M | n/a | n/a | n/a | n/a | -846K | -872K | n/a |
Shares Outstanding (Basic) | 34.85M | 34.82M | 30.02M | 19.77M | 19.53M | 19.59M | 12.37M | 8.58M | 8.58M | 8.42M | 7.2M | 7.2M | 7.2M | 5.92M | 5.92M | 5.1M | 4.9M |
Shares Outstanding (Diluted) | 34.85M | 34.82M | 30.07M | 19.77M | 19.53M | 19.59M | 12.37M | 8.58M | 8.58M | 8.42M | 7.2M | 7.2M | 7.2M | 5.92M | 5.92M | 5.1M | 4.9M |
EPS (Basic) | -0.21 | -0.01 | 0.31 | -0.13 | -0.19 | -0.19 | -0.19 | -0.27 | -0.58 | -0.63 | -0.83 | -0.38 | -0.1 | -0.39 | -0.13 | -0.05 | -1.23 |
EPS (Diluted) | -0.21 | -0.01 | 0.31 | -0.13 | -0.19 | -0.19 | -0.19 | -0.27 | -0.58 | -0.63 | -0.83 | -0.38 | -0.1 | -0.39 | -0.13 | -0.05 | -1.23 |
EBITDA | -7.35M | -238K | 9.28M | -2.62M | -3.56M | -4.05M | -2.29M | -2.26M | -4.96M | -11.54M | -6.05M | -2.61M | -1.94M | -2.14M | -1.06M | -79.83K | -451K |
EBIT | -7.35M | -238K | 9.28M | -2.62M | -3.56M | -4.07M | -2.29M | -2.26M | -4.96M | -7.27M | -5.96M | -2.61M | -1.95M | -2.15M | -1.07M | -91.86K | -6.02M |
Depreciation & Amortization | 10.73M | 7.61K | 13.71M | 90.05K | 7.17K | 18.02K | 345.00 | 1.24K | 1.55K | 1.56K | 3.15K | 3.41K | 3.1K | 9.72K | 12.18K | 12.03K | 12.08K |